Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04548531 · ClinicalTrials.gov registry record · NA
Engaging Patients in Colon Cancer Screening Decisions During COVID-19
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 800
- Enrollment target
NCT04548531: Completed NA study, sponsored by Massachusetts General Hospital.
NCT04548531 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04548531, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
Study Summary
The goal of the study is to examine whether a shared decision making intervention improves decision making about colon cancer screening for patients who had their colonoscopy delayed or postponed due to the COVID pandemic. Eligible patients (n=800) will be randomly assigned to either the intervention or control arm. A subset will be surveyed about 6-8 weeks post intervention to measure shared decision making, their intention to follow through with screening, and their decisional conflict. Study staff will conduct medical chart review to track receipt of colon cancer screening within 6 months. The statistician will test whether patients in the intervention arm report more shared decision making, less decisional conflict, higher intention to follow through on screening and have higher screening rates compared to those in the control arm.
Interventions
- BEHAVIORAL Shared Decision Making
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2020-09-10 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04548531
The ClinicalTrials.gov registry entry for NCT04548531 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shared Decision Making is the first listed.
NCT04548531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04548531 about?
NCT04548531 is a clinical study titled "Engaging Patients in Colon Cancer Screening Decisions During COVID-19". The goal of the study is to examine whether a shared decision making intervention improves decision making about colon cancer screening for patients who had their colonoscopy delayed or postponed due to the COVID pandemic. Eligible patients (n=800) will be randomly assigned to either the interventio...
What is the current status of trial NCT04548531?
This trial is currently completed. It is a NA study. The enrollment target is 800 participants. The study started on 2020-09-10. Estimated completion is 2021-04-30.
What interventions are being tested in trial NCT04548531?
The interventions under investigation include: Shared Decision Making (BEHAVIORAL).
Who is sponsoring clinical trial NCT04548531?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.